{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:08:48Z","timestamp":1648980528346},"reference-count":2,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T00:00:00Z","timestamp":1452038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T00:00:00Z","timestamp":1452038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1002\/pbc.25884","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T12:32:13Z","timestamp":1452169933000},"page":"947-947","source":"Crossref","is-referenced-by-count":0,"title":["Reply to Comment on: Treatment of EBV-Associated Nodular Sclerosing Hodgkin Lymphoma in a Patient With Ataxia Telangiectasia With Brentuximab Vedotin and Reduced COPP Plus Rituximab"],"prefix":"10.1002","volume":"63","author":[{"given":"Michael T.","family":"Meister","sequence":"first","affiliation":[{"name":"Pediatric Clinic; Pediatric Hematology and Oncology; Hospital of the Goethe-University Frankfurt; Frankfurt Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Voss","sequence":"additional","affiliation":[{"name":"Pediatric Clinic; Pediatric Hematology and Oncology; Hospital of the Goethe-University Frankfurt; Frankfurt Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Schwabe","sequence":"additional","affiliation":[{"name":"Pediatric Clinic; Pediatric Hematology and Oncology; Hospital of the Goethe-University Frankfurt; Frankfurt Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,1,6]]},"reference":[{"key":"10.1002\/pbc.25884-BIB0001|pbc25884-cit-0001","article-title":"Comment on: Treatment of EBV-associated nodular sclerosing Hodgkin lymphoma in a patient with ataxia telangiectasia with brentuximab vedotin and reduced COPP plus rituximab","author":"Zielen","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.25884-BIB0002|pbc25884-cit-0002","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/pbc.25621","article-title":"Treatment of EBV-associated nodular sclerosing Hodgkin lymphoma in a patient with ataxia telangiectasia with brentuximab vedotin and reduced COPP plus rituximab","volume":"62","author":"Meister","year":"2015","journal-title":"Pediatr Blood Cancer"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25884","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25884","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pbc.25884\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:12:26Z","timestamp":1498273946000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pbc.25884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,6]]},"references-count":2,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.25884","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,6]]}}}